Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zohra Sattar Waxali"'
Autor:
Ðenana Miodragović, Wenan Qiang, Zohra Sattar Waxali, Željko Vitnik, Vesna Vitnik, Yi Yang, Annie Farrell, Matthew Martin, Justin Ren, Thomas V. O’Halloran
Publikováno v:
Molecules, Vol 26, Iss 17, p 5421 (2021)
Patients with triple negative breast cancers (TNBCs)—highly aggressive tumors that do not express estrogen, progesterone, and human epidermal growth factor 2 receptors—have limited treatment options. Fewer than 30% of women with metastatic TNBC s
Externí odkaz:
https://doaj.org/article/2ece449ef2a24b50aa5f6905ee4d2a06
Traditional Kenyan herbal medicine: exploring natural products’ therapeutics against schistosomiasis
Autor:
Fidensio K. Ndegwa, Chaitanya Kondam, Samuel Y. Aboagye, Taiwo E. Esan, Zohra Sattar Waxali, Margaret E. Miller, Nicholas K. Gikonyo, Paul K. Mbugua, Paul O. Okemo, David L. Williams, Timothy J. Hagen
Publikováno v:
J Helminthol
Praziquantel (PZQ) remains the only drug of choice for the treatment of schistosomiasis, caused by parasitic flatworms. The widespread use of PZQ in schistosomiasis endemic areas for about four decades raises concerns about the emergence of resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c49864d27bbc020da0cc476bf3f398
https://doi.org/10.1017/s0022149x22000074
https://doi.org/10.1017/s0022149x22000074
Autor:
Annie Farrell, Yi Yang, Željko J. Vitnik, Vesna D. Vitnik, Justin Ren, Matthew Martin, Zohra Sattar Waxali, Wenan Qiang, Ðenana Miodragović, Thomas V. O'Halloran
Publikováno v:
Molecules
Volume 26
Issue 17
Molecules, Vol 26, Iss 5421, p 5421 (2021)
Volume 26
Issue 17
Molecules, Vol 26, Iss 5421, p 5421 (2021)
Patients with triple negative breast cancers (TNBCs)—highly aggressive tumors that do not express estrogen, progesterone, and human epidermal growth factor 2 receptors—have limited treatment options. Fewer than 30% of women with metastatic TNBC s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f56f547ff07ef1ae747f657b61ba63
https://doi.org/10.3390/molecules26175421
https://doi.org/10.3390/molecules26175421
Autor:
Thomas V. O'Halloran, Abraham Bogachkov, Zohra Sattar Waxali, Ðenana Miodragović, Elden P. Swindell
Publikováno v:
Inorganica Chim Acta
Platinum drugs (cisplatin, oxaliplatin, and carboplatin) and arsenic trioxide are the only commercial inorganic non-radioactive anticancer drugs approved by the US Food and Drug Administration. Numerous efforts are underway to take advantage of the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec716a1057ae25ab5c745929826b29b
https://doi.org/10.1016/j.ica.2019.119030
https://doi.org/10.1016/j.ica.2019.119030